Relay Therapeutics Job Trends

Your Role You will lead and drive strategy for analytical method development and phase-appropriate method validation/transfer activities supporting full characterization of small molecule NCEs, from early development through late-stage/commercial readiness. Own the analytical strategy for drug substance programs at CDMOs, directing method development, validation, and troubleshooting to enable characterization, release, and stability testing of Relay clinical candidates. Lead the evaluation and introduction of modern analytical technologies, setting direction for how new techniques are incorporated into method development workflows across programs. Provide senior-level review and approval of method transfer/validation protocols, data sets, and reports, ensuring scientific rigor and regulatory readiness. Hold...

The Associate Director, Human Resources Business Partner (HRBP) serves as a trusted advisor to leaders across Research and General & Administrative (G&A) functions, partnering to build high-performing teams and enable organizational effectiveness. This role provides strategic and day-to-day HR business partnership while helping drive and evolve Relay Therapeutics people strategy as the organization continues to grow. Reporting to the Senior Director, HR Business Partner, this individual will independently support client groups across Research and G&A, provide day-to-day HRBP support to Clinical Development as needed, and lead the execution of key enterprise-wide talent initiatives, including performance management, talent management, employee engagement,...

Executive Director/Vice President, Medical Affairs – Genetic Rare Disease The Opportunity As Executive Director/Vice President, Medical Affairs, Vascular Anomalies, you will define and implement all aspects of clinical trial engagement, disease awareness, and medical strategy forRelay Tx’s vascular anomalies program as it advances from late-stage clinical development through launch and commercialization. You will lead the Medical Affairs function through this pivotal transition from late-stage development to commercialization readiness, partnering closely with internal and external stakeholders to develop solutions that drive awareness of Relay Therapeutics' genetic vascular anomaly portfolio, incorporate critical insights into medical strategy, and build external networks and partnerships...